I would much rather be holding Clinuvel with their $1 Million profits every week and growing rather than a cash burner at this stage. CSL has done well today as Healthcare is relatively immune and they like Clinuvel have most of their operation in the US so tariffs are a non issue. Just for anyone who doesn't know, the Clinuvel FDA approved implant is manufactured in the States. Rate cuts, potential falling Aussie dollar, solid earnings from Healthcare sector, no reason to raise capital, near term blockbuster opportunities, $200 Million cash pile that is always growing, a share buyback to use only a tiny portion of that cash pile. Just need management to honour their own words and buyback those 1.5 Million CUV shares and not splash any cash on Michelin catered Soirees in Monaco. Lots of Healthcare companies are out there right now buying back their own shares in a straightforward manner as they stated, it's a simple process and sends a great signal to existing and potential investors that management are looking out for them.
All IMO DYOR
CUV Price at posting:
$10.55 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)